http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108042494-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00351 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate | 2018-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108042494-B |
| titleOfInvention | Method for treating arrhythmia by combining radiofrequency ablation with liposome drug |
| abstract | The invention relates to a method for treating arrhythmia by combining radiofrequency ablation with liposome medicine, which comprises the following steps: firstly, performing cardiac radio frequency ablation; the second step is that: immediately after the operation, the patient is injected with adriamycin liposome liquid medicine intravenously or is infused with adriamycin liposome liquid medicine intravenously. The invention also provides a new application of the adriamycin liposome. Its advantages are: the method can further kill residual electrically conductive cells after radiofrequency ablation, can effectively reduce the recurrence rate after atrial fibrillation ablation, is a brand new means for treating complex arrhythmia, is simple and safe to operate, has obvious effect, has no obvious wound in the intravenous injection process, and is easy to accept by patients. |
| priorityDate | 2018-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365 |
Total number of triples: 23.